AR MPJE flashcards
AR MPJE · Build recall with a focused review session.
33 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Legend drug
- A drug that federal law requires to be dispensed only on a prescription because it is not safe for self-medication without professional supervision.
- Arkansas Board of Pharmacy
- The state agency that licenses pharmacists, pharmacies, and technicians and enforces Arkansas pharmacy law and Board rules.
- Pharmacist-in-charge
- The Arkansas-licensed pharmacist designated by a pharmacy as responsible for compliance with all laws, rules, and recordkeeping requirements at that location.
- DEA Form 222
- The federal order form, or its CSOS electronic equivalent, required to purchase Schedule I or II controlled substances from a supplier.
- Biennial inventory
- A complete count of controlled substances taken every two years on the registrant's inventory date, with exact counts for Schedule II and estimated counts for III-V.
- Schedule II refills
- Federal law prohibits refills on Schedule II prescriptions; a new prescription is required for additional dispensing.
- Emergency oral Schedule II
- An oral Schedule II prescription allowed in an emergency if the prescriber delivers a written prescription within seven days; otherwise the pharmacist notifies DEA.
- Partial fill Schedule II
- A partial dispensing of a Schedule II prescription permitted when the pharmacist cannot supply the full quantity; the remainder must be dispensed within 72 hours.
- Patient counseling
- Required communication by a pharmacist or intern on new prescriptions covering drug name, directions, precautions, and significant side effects, unless the patient declines.
- DEA Form 106
- The federal form used to report the theft or significant loss of controlled substances to DEA, generally within one business day of discovery.
- DEA Form 41
- The federal form used to document the destruction of controlled substances, which must be witnessed and retained for two years.
- CSOS
- The DEA's Controlled Substance Ordering System, an electronic equivalent of Form 222 that uses digital certificates for ordering Schedule I and II drugs.
- Combat Methamphetamine Act
- Federal law limiting retail sales of ephedrine and pseudoephedrine to 3.6 grams per day and 9 grams per 30 days per purchaser, with logbook and ID checks.
- DSCSA
- The federal Drug Supply Chain Security Act requiring transaction documentation and verification of prescription drugs as they move through the supply chain.
- Arkansas pharmacy license
- A license issued by the Arkansas Board of Pharmacy for a specific physical location; changes in location, ownership, or name require Board notification or a new application.
- Pharmacy technician
- A Board-registered Arkansas pharmacy worker who assists under pharmacist supervision but may not counsel patients or perform final verification of a prescription.
- Continuing education
- Biennial renewal requirement for Arkansas pharmacists that includes Board-specified hours in topics such as pharmacy law and patient safety.
- Prescription labeling
- Required label content including pharmacy name and address, prescription number, date, patient and prescriber names, directions, and drug name and strength.
- Generic substitution
- Dispensing a therapeutically equivalent generic drug unless the prescriber writes 'dispense as written' or the patient requests the brand.
- Record retention
- Arkansas and federal requirement that prescription and controlled substance records be kept for at least two years and be readily retrievable for inspection.
- Schedule III-V transfers
- Federal rule allowing a Schedule III-V prescription to be transferred once between pharmacies with documentation; Schedule II prescriptions may not be transferred.
- Schedule V sales
- Sales of certain Schedule V drugs without a prescription are permitted only under state law conditions, including age and logbook requirements in Arkansas.
- Patient profile
- A pharmacy record containing the patient's allergies, current medications, and diagnoses used to screen for interactions and duplicative therapy.
- Medication error reporting
- Documentation and review of dispensing and medication errors through a continuous quality improvement program required in Arkansas pharmacies.
- Child-resistant packaging
- Safety packaging required for most prescriptions unless the patient or prescriber requests otherwise or the drug is exempt.
- Confidentiality
- The duty under HIPAA and Arkansas law to protect patient records and release them only with authorization or as required by law.
- Immunization authority
- Arkansas authorization for pharmacists to administer vaccines to specified age groups under a protocol or prescription, with training and reporting requirements.
- AR-IIS
- The Arkansas Immunization Information System, to which pharmacists must report vaccines administered as required by state law.
- Collaborative practice agreement
- A written agreement between a pharmacist and prescriber, permitted under Arkansas Board rules, defining scope and protocols for managing drug therapy.
- Naloxone standing order
- An Arkansas protocol allowing pharmacists to dispense naloxone to persons at risk of opioid overdose without an individual prescription.
- VAERS
- The federal Vaccine Adverse Event Reporting System to which pharmacists report adverse events following immunization.
- DEA registration
- Federal registration required for each principal place of business where controlled substances are dispensed, stored, or distributed, renewed every three years.
- Schedule II filing
- Arkansas requirement that Schedule II prescriptions be filed separately from other prescriptions and retained for at least two years.